Current Opinions on the Clinical Utility of Ravulizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria
Carmelo Gurnari,1,2 Ishani Nautiyal,1 Simona Pagliuca1,3 1Department of Translational Hematology and Oncology Research, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, OH, USA; 2Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology,...
Saved in:
Main Authors: | Gurnari C (Author), Nautiyal I (Author), Pagliuca S (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab
by: Richard Kelly, et al.
Published: (2009) -
Paroxysmal Nocturnal Hemoglobinuria Superimposed with Preeclampsia
by: Mann-Ling Chen, et al.
Published: (2006) -
Hemoglobinúria paroxística noturna e gravidez Paroxysmal nocturnal hemoglobinuria in pregnancy
by: Marcelo Luís Nomura, et al.
Published: (2004) -
Paroxysmal Nocturnal Hemoglobinuria: Diagnostic Challenges in Pediatric Patient
by: Dharshana Krishnaprasadh, et al.
Published: (2019) -
Treatment of paroxysmal nocturnal hemoglobinuria in pregnancy with eculizumab: A case report
by: Michael J. Fassett, et al.
Published: (2021)